Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

Completed · Phase 1

Conditions studied: Adolescent Substance Abuse, Attention Deficit Hyperactivity Disorder

In brief

The goal of this proposal is to develop and pilot a brief protocol designed to systematically integrate pharmacological interventions for attention deficit hyperactivity disorder (ADHD) into behavioral treatment services for adolescent substance users with comorbid ADHD in everyday care. ADHD is a prevalent co-occurring condition for adolescent substance use (ASU) that can significantly impede successful ASU treatment but is vastly under-diagnosed and undertreated among ASU clients in agency settings. Moreover, ADHD medication acceptance and compliance is particularly difficult to achieve in high-risk adolescent populations.

Key facts

Study ID
NCT01539941
Run by
The National Center on Addiction and Substance Abuse at Columbia University
People needed
14
Starts
2011-08-01
Expected to finish
2014-05-01
Last updated by the study team
2015-08-04

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.